General Range
FORIXONE-TZ 1.125G
Price on request/100 · MOQ 100 boxes
FORIXONE-TZ 1.125G Injection by Fortune Labs contains Ceftriaxone 1000 mg and Tazobactam 125 mg, an antibiotic combination formulated for managing selected bacterial infections. Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, while Tazobactam helps protect it against certain bacterial beta-lactamase enzymes. This formulation may be prescribed for susceptible respiratory tract, urinary tract, intra-abdominal, and skin infections when clinically appropriate. Available in a 1.125 gm single-dose vial, FORIXONE-TZ is part of Fortune Labs' injectable pharmaceutical portfolio. Fortune Labs offers Injection PCD Pharma Franchise and distribution opportunities across India. Contact Fortune Labs for wholesale pricing, product availability, monopoly franchise opportunities, and business enquiries. Administer only under qualified medical supervision.
CategoryGeneral Range
Min. Order100 boxes
Supplied byFortune Labs
CertificationWHO-GMP, ISO
Prices are indicative and set by the listing company. Confirm net rates, packing and stock availability directly with the supplier.
Specifications
- Composition
- Ceftriaxone 1000 mg (1 gm) + Tazobactam 125 mg
- Packaging Type
- Glass Vial with Diluent Ampoule and Outer Carton
- Packaging Size
- 1.125 gm Single-Dose Vial
- Dosage Form
- Injection
- Treatment
- Bacterial respiratory tract infections, pneumonia, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, and other se
- Shelf Life
- 24 Months
- Storage
- Store below 30°C, protect from light & moisture
- Certification
- WHO-GMP, ISO
Company Info
Fortune LabsPanchkula, Haryana
Fortune Labs is an Indian pharmaceutical and PCD (Propaganda Cum Distribution) pharma franchise company based in Panchkula, Haryana.
Key Details
• Headquarters: S.C.F 258, 1st Floor, Sector 16, Panchkula, Haryana, India
• Establishment: Founded in 2008 (sister concern of Prosperity 6 Pharmaceutics in Baddi)
• CEO / Leadership: Mayank Bansal
• Certifications: ISO 9001, WHO-GMP, and DCGI-approved formulations
• Business Model: Offers Pan-India PCD pharma franchises with monopoly rights, third-party manufacturing, and marketing support.
Product Portfolio & Therapeutic Ranges
• Formulations: Tablets, capsules, syrups, dry powders, injectables, ointments, gels, eye/ear/nasal drops, softgel capsules, and Ayurvedic/herbal products.
• Therapeutic Segments: Antibiotics, cardiac and diabetic care, orthopedics, dermatology, gynaecology, paediatrics, gastrointestinal/PPI ranges, neurology, antihistamines/cough-cold, and nutritional supplements.
Would you like information on how to apply for a franchise partnership or specific product price lists from Fortune Labs?
More General Range
